Munich, Germany

Gerald Beste

This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Pieris Ag. Active years: 2007-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerald Beste. Retrieved from https://idiyas.com/inventor/gerald-beste-kmqi4n7b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 25.0


Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 130(Granted Patents)


Company Filing History:


Years Active: 2007-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gerald Beste: Innovator in Anticalin Technology

Introduction: Gerald Beste is a pioneering inventor based in Munich, Germany, known for his significant contributions to the field of biotechnology. With a total of four patents to his name, he plays a crucial role in advancing innovative protein engineering solutions.

Latest Patents: One of Beste's latest inventions revolves around Anticalins, which are novel proteins designed to exhibit binding activities for specific ligands. This groundbreaking invention involves modifying the structure of peptides from the lipocalin family through amino acid replacements in their natural ligand binding pockets, utilizing advanced genetic engineering techniques. These anticalins function similarly to immunoglobulins, enabling the identification and binding of various molecular structures, making them integral to various applications in biotechnology and drug development.

Career Highlights: Gerald Beste's career is marked by his association with Pieris AG, a company at the forefront of biopharmaceutical innovations. His work has established him as a key figure in protein engineering, allowing for the creation of more efficient and targeted therapeutic solutions.

Collaborations: Throughout his career, Beste has collaborated with esteemed colleagues, including Thomas Stibora and Frank Schmidt. Together, they contribute to advancing research and development in the field, further enhancing the potential of their innovations.

Conclusion: Gerald Beste's ingenuity in the realm of anticalin technology showcases the power of innovative thinking in the biotechnology industry. His ongoing contributions at Pieris AG not only exemplify his dedication to scientific advancement but also pave the way for future breakthroughs in the development of therapeutic proteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…